Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Combinations of modafinil and an antidepressant agent claimed by Cephalon

Jan. 18, 2005

Low-dose doxepin therapy shows promise in primary sleep maintenance insomnia

Jan. 18, 2005

PARP inhibitor reduces brain infarct size in rats

Jan. 17, 2005

KCNQ2 channel activators for epilepsy, neuropathic pain, etc.

Jan. 17, 2005

Long-term vitamin E supplementation reported to reduce mortality due to ALS

Jan. 17, 2005

Approvable letter for Biovail's orally disintegrating tramadol

Jan. 17, 2005

MEM-1003 enters U.S. safety and tolerability study for Alzheimer's

Jan. 17, 2005

Sirna and Targeted Genetics form Huntington's disease collaboration

Jan. 17, 2005

Sepracor and Acadia announce CNS R&D collaboration

Jan. 17, 2005

AstraZeneca prepares and tests vanilloid receptor antagonists

Jan. 14, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...